Atezolizumab in combination with bevacizumab, paclitaxel and carboplatin for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, including patients with EGFR mutations Article

Industry Collaboration International Collaboration

cited authors

  • Reck, Martin; Shankar, Geetha; Lee, Anthony; Coleman, Shelley; McCleland, Mark; Papadimitrakopoulou, Vassiliki A.; Socinski, Mark A.; Sandler, Alan

authors

Publication Date

  • December 14, 2019

webpage

published in

category

keywords

  • Atezolizumab
  • bevacizumab

start page

  • 125

end page

  • 136

volume

  • 14

issue

  • 2